Foodborne infections persist, but chemical exposure and ultraprocessed foods now play a larger role in shaping long-term ...

With Singapore as its new global headquarters, Leo International Group is in the process of establishing a Family Office to ...

A SUPPLEMENT loved by the likes of Jennifer Aniston and Hailey Bieber could reverse Alzheimer’s and restore brain function, a ...

Mongolian shamans beat wicker drums to summon ancestral spirits. A Peruvian man in a headdress unleashes a piercing ululation ...

Novel next-generation Bruton tyrosine kinase (BTK)-targeted protein degrader APG-3288 has received investigational new drug ...

Arcus’s highest priority is to execute on its ongoing Phase 3 trial and overall development plan aimed at establishing casdatifan as the standard-of-care and backbone therapy for clear cell renal cell ...

Here, BioSpace looks back at the biggest acquisition deals of 2025. Target: Intra-Cellular Therapies Acquisition date: ...

Par Health, Inc. ("Par Health" or the "Company") today announced the appointment of Dr. William ("Bill") Larkins as Executive Vice President and Chief Scientific Officer and President, Sterile ...

This year was another full of change for our news team, which saw the exit of two news writers midyear. Our other staff ...

Hot pools, ice plunges, saunas and other body treatments are now available in Singapore's new wellness spaces. Read more at ...

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical stage innovative drug development company focused on developing innovative therapies for immune and ...

Novel next-generation Bruton tyrosine kinase (BTK)-targeted protein degrader APG-3288 has received investigational new drug (IND) clearance from the U.S. FDA, marking another major expansion to the co ...